Locations of visitors to this page FAIR USE NOTICE This site contains copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available in our efforts to advance understanding of issues of ecological, political and humanitarian significance. We believe this constitutes a ‘fair use’ of any such copyrighted material as provided for in section 107 of the US Copyright Law. In accordance with Title 17 U.S.C. Section 107, the material on this site is distributed without profit to those who have expressed a prior interest in receiving the included information for research and educational purposes. DISCLAIMER: Any medical information published on this blog is not intended as a substitute for informed medical advice and you should not take any action before consulting with your personal physician or a health care provider.

Tuesday, January 14, 2014

Innovator Liability and Brand-Name Pharmaceuticals

Innovator Liability and Brand-Name Pharmaceuticals Kelly E. Jones, a partner at Harris Beach, discusses innovator liability, which is premised on the notion that a brand-name pharmaceutical manufacturer that allegedly produced inadequate labeling on its brand-name drug has a legal duty to warn consumers, even those who ingested the competing generic version, and how this theory has fared in the courts.


No comments: